Wealthfront’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Wealthfront’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-73	Closed	-$2K	–	1207
2015 Q3	$2K	Buy	+73	New	+$3.12K	﹤0.01%	1179

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wealthfront's DPLO Position: Q4 2015 in Review

Wealthfront sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2015, closing a stake of 73 shares — an estimated $2K sold.

Wealthfront first reported a position in DPLO in Q3 2015 and held it in 1 quarter. The position peaked at $2K in Q3 2015. 151 funds tracked by Wall St. Rank hold DPLO as of Q4 2015.

Wealthfront reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2015 after selling out during the quarter.
Wealthfront sold 73 DIPLOMAT PHARMACY, INC. shares in Q4 2015, an estimated $2K.
Wealthfront first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 1 quarter.
Wealthfront's DIPLOMAT PHARMACY, INC. position peaked at $2K in Q3 2015.
151 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.